TY - JOUR
T1 - Far-infrared stimulation of Neiguan acupoints improves heart rate variability and ameliorate fatigue in hemodialysis patients
T2 - A randomized trial
AU - Liao, Ling Yu
AU - Chien, Li Wei
AU - Liu, Chi Feng
N1 - Publisher Copyright:
Copyright © 2024, the Chinese Medical Association. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
PY - 2024/3/1
Y1 - 2024/3/1
N2 - Background: In 2018, 84 615 patients in Taiwan received hemodialysis, of which about 62% to 97% suffered from fatigue. Fatigue caused by hemodialysis may be mental or physical. However, the detailed mechanism remains unclear. This study aimed to evaluate whether far-infrared stimulation of the Neiguan acupoint (P6) could effectively reduce fatigue and improve heart rate variability (HRV) in hemodialysis patients. Methods: We conducted a two-arm, randomized trial in a hemodialysis center between March 2015 and March 2016. A total of 73 hemodialysis patients were included and were randomly assigned to an experimental group (n = 37) and a control group (n = 36). The experimental group received far-infrared radiation on Neiguan acupoint during hemodialysis for 12 weeks. The outcomes were fatigue level and HRV. Results: All patients showed moderate fatigue (M = 26.00 ± 13.01, range = 0-78) at baseline. Far-infrared stimulation on Neiguan acupoint significantly reduced overall fatigue (β = 24, p < 0.001) and improved HRV (β = 74.36, p < 0.001). Compared to the control group, the experiment group had significantly reduced fatigue levels in all aspects such as reduced energy and motivation (β = −2.97, p < 0.001), reduced physical strength (β = −1.28, p < 0.01), reduced mental capability (β = −2.38, p < 0.001), reduction in daily activities (β = −1.48, p < 0.01), depressed mood and loss of control (β = −1.21, p< 0.05) as well as increased autonomous nervous system activity (β = 14.71, p < 0.01) in the third month of stimulation. Conclusion: Far-infrared stimulation of the Neiguan acupoints effectively reduces fatigue and increases autonomic nervous system activity in hemodialysis patients.
AB - Background: In 2018, 84 615 patients in Taiwan received hemodialysis, of which about 62% to 97% suffered from fatigue. Fatigue caused by hemodialysis may be mental or physical. However, the detailed mechanism remains unclear. This study aimed to evaluate whether far-infrared stimulation of the Neiguan acupoint (P6) could effectively reduce fatigue and improve heart rate variability (HRV) in hemodialysis patients. Methods: We conducted a two-arm, randomized trial in a hemodialysis center between March 2015 and March 2016. A total of 73 hemodialysis patients were included and were randomly assigned to an experimental group (n = 37) and a control group (n = 36). The experimental group received far-infrared radiation on Neiguan acupoint during hemodialysis for 12 weeks. The outcomes were fatigue level and HRV. Results: All patients showed moderate fatigue (M = 26.00 ± 13.01, range = 0-78) at baseline. Far-infrared stimulation on Neiguan acupoint significantly reduced overall fatigue (β = 24, p < 0.001) and improved HRV (β = 74.36, p < 0.001). Compared to the control group, the experiment group had significantly reduced fatigue levels in all aspects such as reduced energy and motivation (β = −2.97, p < 0.001), reduced physical strength (β = −1.28, p < 0.01), reduced mental capability (β = −2.38, p < 0.001), reduction in daily activities (β = −1.48, p < 0.01), depressed mood and loss of control (β = −1.21, p< 0.05) as well as increased autonomous nervous system activity (β = 14.71, p < 0.01) in the third month of stimulation. Conclusion: Far-infrared stimulation of the Neiguan acupoints effectively reduces fatigue and increases autonomic nervous system activity in hemodialysis patients.
KW - Autonomic nervous system
KW - Fatigue
KW - Hemodialysis
UR - http://www.scopus.com/inward/record.url?scp=85186641879&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85186641879&partnerID=8YFLogxK
U2 - 10.1097/JCMA.0000000000001060
DO - 10.1097/JCMA.0000000000001060
M3 - Article
C2 - 38289295
AN - SCOPUS:85186641879
SN - 1726-4901
VL - 87
SP - 340
EP - 345
JO - Journal of the Chinese Medical Association
JF - Journal of the Chinese Medical Association
IS - 3
ER -